Quantcast

Latest Inovio Pharmaceuticals Inc. Stories

2014-02-26 16:28:53

BLUE BELL, Pa., Feb. 26, 2014 /PRNewswire/ -- Inovio Pharmaceuticals, Inc. (NYSE MKT: INO) ("Inovio" or the "Company"), today announced that it intends to offer and sell shares of its common stock in an underwritten public offering. Piper Jaffray & Co. and Stifel, Nicolaus & Company, Incorporated are acting as joint bookrunning managers for the offering. The offering is subject to market conditions, and there can be no assurance as to whether or when the offering may be...

2014-02-19 04:22:25

BLUE BELL, Pa., Feb. 19, 2014 /PRNewswire/ -- Inovio Pharmaceuticals, Inc. (NYSE MKT: INO) announced today that President and CEO, Dr. J. Joseph Kim, will present a corporate overview of the company at the Cowen and Company 34th Annual Health Care Conference in Boston, MA. Cowen and Company 34th Annual Health Care Conference March 3-5, 2014Boston Marriott Copley PlaceBoston, MA Inovio PresentationMonday, March 3(rd)2:50 PM ET A live and archived webcast of Dr. Kim's presentation...

2014-02-18 04:21:13

New VPs of R&D and Clinical Development add extensive pharmaceutical and biotech immunotherapy product development experience BLUE BELL, Pa., Feb. 18, 2014 /PRNewswire/ -- Inovio Pharmaceuticals, Inc. (NYSE MKT: INO) today announced it has expanded its senior management team with two appointments to help advance the company's growing pipeline of preclinical and clinical DNA vaccines. Inovio has appointed Dr. Laurent Humeau as Vice President of R&D and Dr. Jan Marie-Albert Van...

2014-02-11 04:22:09

2014 Marks A Transformative Year for the Leader in DNA Vaccines and Cancer Immunotherapies BLUE BELL, Pa., Feb. 11, 2014 /PRNewswire/ -- Inovio Pharmaceuticals, Inc. (NYSE MKT: INO) announced today that it has been invited by the New York Stock Exchange to ring the Opening Bell(®) tomorrow, February 12(th), to mark the beginning of an exciting year for the company in which it will reveal all-important phase II efficacy and immune response data for its lead cancer immunotherapy;...

2014-01-30 04:21:58

BLUE BELL, Pa., Jan. 30, 2014 /PRNewswire/ -- Inovio Pharmaceuticals, Inc. (NYSE MKT: INO) announced today that President and CEO, Dr. J. Joseph Kim, will present a corporate overview of the company at the 16(th) Annual BIO CEO & Investor Conference in New York, NY. BIO CEO & Investor Conference February 10-11, 2014The Waldorf Astoria New York, NY Inovio PresentationTuesday, February 1110:30 AM ET A live webcast of Dr. Kim's Biotech Showcase presentation can be accessed at...

2014-01-23 04:21:21

Inovio develops DNA-based immune booster (IL-33) that enhances T-cell responses and generates effective CD8 mediated tumor regression BLUE BELL, Pa., Jan. 23, 2014 /PRNewswire/ -- Inovio Pharmaceuticals, Inc. (NYSE MKT: INO) today unveiled that the company has developed a new DNA-based cytokine immune activator, interleukin -33 (IL-33), that in combination with optimized DNA vaccines delivered by electroporation increased the potency and efficacy of the therapeutic response to the...

2014-01-06 04:21:48

BLUE BELL, Pa., Jan. 6, 2014 /PRNewswire/ -- Inovio Pharmaceuticals, Inc. (NYSE MKT: INO) announced today that Dr. J. Joseph Kim, President and CEO, will present a corporate overview of the company at the Biotech Showcase 2014 investor conference in San Francisco, CA. Biotech Showcase 2014 January 13-15Parc55 HotelSan Francisco, CA Inovio PresentationMonday, January 133:30 PM PT A live webcast of Dr. Kim's Biotech Showcase presentation can be accessed at the following URL:...


Word of the Day
snash
  • To talk saucily.
  • Insolent, opprobrious language; impertinent abuse.
This word is Scots in origin and probably imitative.